The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

Guo J, Jin D, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Miao S, Xi S

DOI: 10.1016/j.ebiom.2018.08.001
Published: 2018 Sep
Container: EBioMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ebiom.2018.08.001,
  title = {The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.},
  author = {Guo J and Jin D and Wu Y and Yang L and Du J and Gong K and Chen W and Dai J and Miao S and Xi S},
  year = {2018},
  journal = {EBioMedicine},
  doi = {10.1016/j.ebiom.2018.08.001},
  url = {https://doi.org/10.1016/j.ebiom.2018.08.001}
}

RIS

TY  - JOUR
TI  - The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
AU  - Guo J
AU  - Jin D
AU  - Wu Y
AU  - Yang L
AU  - Du J
AU  - Gong K
AU  - Chen W
AU  - Dai J
AU  - Miao S
AU  - Xi S
PY  - 2018
JO  - EBioMedicine
DO  - 10.1016/j.ebiom.2018.08.001
UR  - https://doi.org/10.1016/j.ebiom.2018.08.001
ER  -

APA

J, G., D, J., Y, W., L, Y., J, D., K, G., W, C., J, D., S, M., & S, X. (2018). The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2018.08.001

Source records

pubmed · retrieved 2026-09-25T02:24:57.557Z
europe-pmc · retrieved 2026-09-25T02:24:57.591Z
doaj · retrieved 2026-09-25T02:24:57.558Z